0 items USD 0.00Search
Your search for "technavio global hospital acquired disease testing market 2015 2019" gave back 1549437 results.
The global market for biopsy devices is predicted to exceed US$ 3 Billion by 2025. Biopsy devices are gaining traction within the industry as a...
iGATE
March 2020
Price: USD 2,190.00
HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
HAI is a term used to describe all infections that do not stem from the patient’s original diagnosis on admission. HAIs are caused by bacteria,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Hospital-Acquired Infection Control market size was valued at US$ 5578.1 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. The global Hospital Acquired...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hospital Acquired Pneumonia (HAP) (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
March 2021
Price: USD 2,500.00
Highlights The global Infectious Disease Rapid Diagnostic Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
July 2020
Price: USD 2,000.00
The global Hospital Acquired Infection Treatment market size was valued at US$ 18440 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Hospital Acquired Pneumonia Drugs market size was valued at US$ 2746.4 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48–72 hours after...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
January 2020
Price: USD 2,000.00
Hospital Acquired Pneumonia (HAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
Theranos Scandal - Silicon Valley Scandal Indicative of the Current Investment Culture Summary The news of the Theranos’ scandal, given the previous...
MarketLine
January 2022
Price: USD 995.00
The 2015 study has 223 pages, 85 tables and figures. Worldwide Cardiac and Lung surgical robot markets are poised to achieve significant growth as...
Catalog:
WinterGreen Research
December 2015
Price: USD 4,000.00
